• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于管理巴氏涂片检查中不典型鳞状细胞(ASCUS)的人乳头瘤病毒分流检测或重复巴氏涂片检查:是否有过程实用性的证据?

HPV triage testing or repeat Pap smear for the management of atypical squamous cells (ASCUS) on Pap smear: is there evidence of process utility?

作者信息

Howard Kirsten, Salkeld Glenn, McCaffery Kirsten, Irwig Les

机构信息

Screening and Test Evaluation Program, School of Public Health, University of Sydney, Sydney, NSW, Australia.

出版信息

Health Econ. 2008 May;17(5):593-605. doi: 10.1002/hec.1278.

DOI:10.1002/hec.1278
PMID:17764095
Abstract

A two-stage standard gamble was used to evaluate women's preferences for alternative managements of atypical squamous cells of undermined significance (ASCUS) on Pap smear (repeat Pap smear compared with immediate HPV test), and to test for the evidence of process utility. Women's utilities for the health state scenarios were clustered towards the upper end of the 0-1 scale with considerable variability in women's preferences. There was evidence of process utility, with immediate human papillomavirus (HPV) testing strategies having lower valuations than repeat Pap smear, where the clinical outcome was the same. Mean (95% CI) utilities for HPV testing (negative test) followed by resolution were 0.9967 (0.9957-0.9978) compared with repeat Pap smear followed by resolution: 0.9972 (0.9964-0.9980). Mean (95% CI) utilities for immediate HPV testing (positive test), followed by colposcopy, biopsy and treatment were 0.9354 (0.8544-1.0) compared with repeat Pap smear followed by colposcopy, biopsy and treatment: 0.9656 (0.9081-1.0). Our results add to the existing evidence that the impact of healthcare interventions on well-being is not limited to the effect of the intervention on the health outcomes expected from the intervention; process of care can have quality of life implications for the individual. A modelled application of trial-based data will allow characterisation of the true population costs, benefits, risks and harms of alternative triage strategies and subsequent policy implications thereof.

摘要

采用两阶段标准博弈法评估女性对于巴氏涂片检查中意义不明确的非典型鳞状细胞(ASCUS)的不同处理方式(重复巴氏涂片与立即进行人乳头瘤病毒(HPV)检测)的偏好,并检验过程效用的证据。女性对健康状态情景的效用值集中在0至1量表的上端,女性偏好存在相当大的差异。有证据表明存在过程效用,在临床结果相同的情况下,立即进行HPV检测策略的估值低于重复巴氏涂片。HPV检测(检测结果为阴性)随后病情缓解的平均(95%可信区间)效用值为0.9967(0.9957 - 0.9978),而重复巴氏涂片随后病情缓解的平均(95%可信区间)效用值为0.9972(0.9964 - 0.9980)。立即进行HPV检测(检测结果为阳性),随后进行阴道镜检查、活检和治疗的平均(95%可信区间)效用值为0.9354(0.8544 - 1.0),而重复巴氏涂片随后进行阴道镜检查、活检和治疗的平均(95%可信区间)效用值为0.9656(0.9081 - 1.0)。我们的结果进一步证明,医疗保健干预对幸福感的影响不仅限于干预对预期健康结果的作用;护理过程可能对个体生活质量产生影响。基于试验数据的模型应用将有助于描述不同分诊策略的真实总体成本、效益、风险和危害及其后续政策影响。

相似文献

1
HPV triage testing or repeat Pap smear for the management of atypical squamous cells (ASCUS) on Pap smear: is there evidence of process utility?用于管理巴氏涂片检查中不典型鳞状细胞(ASCUS)的人乳头瘤病毒分流检测或重复巴氏涂片检查:是否有过程实用性的证据?
Health Econ. 2008 May;17(5):593-605. doi: 10.1002/hec.1278.
2
HPV testing in the evaluation of the minimally abnormal Papanicolaou smear.HPV检测在轻度异常巴氏涂片评估中的应用
Am Fam Physician. 1999 May 15;59(10):2794-801.
3
HPV testing versus repeat Pap testing for the management of a minor abnormal Pap smear: evaluation of a decision aid to support informed choice.人乳头瘤病毒检测与重复巴氏涂片检测用于处理轻度异常巴氏涂片结果:对一种支持知情选择的决策辅助工具的评估
Patient Educ Couns. 2008 Dec;73(3):473-9, 481. doi: 10.1016/j.pec.2008.07.021. Epub 2008 Aug 30.
4
HPV DNA testing in the triage of atypical squamous cells of undetermined significance (ASCUS): cost comparison of two methods.人乳头瘤病毒(HPV)DNA检测在意义不明确的非典型鳞状细胞(ASCUS)分流中的应用:两种方法的成本比较
Diagn Cytopathol. 2005 Aug;33(2):138-43. doi: 10.1002/dc.20316.
5
Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.人乳头瘤病毒(HPV)检测和巴氏涂片检查作为子宫颈原位腺癌(AIS)保守治疗预后的预测指标。
Gynecol Oncol. 2007 Jul;106(1):170-6. doi: 10.1016/j.ygyno.2007.03.016. Epub 2007 May 4.
6
Human papilloma virus testing knowledge and attitudes among women attending colposcopy clinic with ASCUS/LGSIL pap smears.在因非典型鳞状细胞意义不明确/低度鳞状上皮内病变巴氏涂片而前往阴道镜诊所就诊的女性中,人乳头瘤病毒检测的知识和态度。
J Obstet Gynaecol Can. 2004 Sep;26(9):788-92. doi: 10.1016/s1701-2163(16)30149-9.
7
Assessing the role of education in women's knowledge and acceptance of adjunct high-risk human Papillomavirus testing for cervical cancer screening.评估教育在女性对宫颈癌筛查中辅助高危型人乳头瘤病毒检测的知识和接受度方面所起的作用。
J Low Genit Tract Dis. 2009 Apr;13(2):66-71. doi: 10.1097/LGT.0b013e31818a53f0.
8
European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.欧洲宫颈癌筛查质量保证指南:宫颈细胞学异常的临床管理建议,第1部分
Cytopathology. 2008 Dec;19(6):342-54. doi: 10.1111/j.1365-2303.2008.00623.x.
9
[Colposcopic-histologic results in 97 patients with mild dysplasia shown by Pap test].[97例巴氏试验显示轻度发育异常患者的阴道镜组织学结果]
Minerva Ginecol. 1991 Nov;43(11):509-12.
10
Australian women's needs and preferences for information about human papillomavirus in cervical screening.澳大利亚女性对于子宫颈癌筛查中人类乳头瘤病毒信息的需求及偏好。
J Med Screen. 2005;12(3):134-41. doi: 10.1258/0969141054855238.

引用本文的文献

1
Conceptualising 'Benefits Beyond Health' in the Context of the Quality-Adjusted Life-Year: A Critical Interpretive Synthesis.在质量调整生命年背景下对“健康之外的益处”进行概念化:一项批判性解释性综述
Pharmacoeconomics. 2021 Dec;39(12):1383-1395. doi: 10.1007/s40273-021-01074-x. Epub 2021 Aug 23.
2
Economic evaluation of process utility: elucidating preferences for a non-invasive procedure to treat restenosis.治疗效用的经济评估:阐明对一种治疗再狭窄的非侵入性手术的偏好。
Health Econ Rev. 2021 Jul 23;11(1):27. doi: 10.1186/s13561-021-00327-x.
3
Cohort profile: indigenous human papillomavirus and oropharyngeal squamous cell carcinoma study - a prospective longitudinal cohort.
队列特征描述:土著人乳头瘤病毒与口咽鳞状细胞癌研究——一项前瞻性纵向队列研究。
BMJ Open. 2021 Jun 3;11(6):e046928. doi: 10.1136/bmjopen-2020-046928.
4
Evaluation of human-papillomavirus screening for cervical cancer in China's rural population.中国农村人口宫颈癌人乳头瘤病毒筛查评估
PeerJ. 2019 Dec 20;7:e8152. doi: 10.7717/peerj.8152. eCollection 2019.
5
Disutility associated with cancer screening programs: A systematic review.癌症筛查计划相关的不适用性:系统评价。
PLoS One. 2019 Jul 24;14(7):e0220148. doi: 10.1371/journal.pone.0220148. eCollection 2019.
6
Human Papillomavirus and Oropharyngeal Cancer Among Indigenous Australians: Protocol for a Prevalence Study of Oral-Related Human Papillomavirus and Cost-Effectiveness of Prevention.澳大利亚原住民中的人乳头瘤病毒与口咽癌:口腔相关人乳头瘤病毒患病率研究及预防成本效益分析方案
JMIR Res Protoc. 2018 Jun 8;7(6):e10503. doi: 10.2196/10503.
7
Estimation of utility weights for human papilloma virus-related health states according to disease severity.根据疾病严重程度估算人乳头瘤病毒相关健康状态的效用权重。
Health Qual Life Outcomes. 2016 Nov 28;14(1):163. doi: 10.1186/s12955-016-0566-8.
8
Valuing Meta-Health Effects for Use in Economic Evaluations to Inform Reimbursement Decisions: A Review of the Evidence.重视元健康效应以用于经济评估以指导报销决策:证据综述
Pharmacoeconomics. 2017 Mar;35(3):347-362. doi: 10.1007/s40273-016-0470-4.
9
A survey of population-based utility scores for cervical cancer prevention.一项基于人群的宫颈癌预防效用评分调查。
BMC Res Notes. 2014 Dec 11;7:899. doi: 10.1186/1756-0500-7-899.
10
Capturing disutility from waiting time.从等待时间中获取负效用。
Pharmacoeconomics. 2014 Apr;32(4):423-4. doi: 10.1007/s40273-014-0129-y.